Home/Products /glycopyrronium-25-mcg-formoterol-fumarate-6-mcg-rota-cap

Pulmonary Rota cap in pharma franchise in Mizoram

Pulmonary Rota cap in PCD pharma franchise in Shillong

Pulmonary Rota cap in top pharma company in Bhubaneswar

Pulmonary Rota cap in pcd pharma supplier in Ranchi

Pulmonary Rota capin phama franchise company in India

Pulmonary Rota cap in phama distributor in Amritsar

Therapeutic

ENDOCRINOLOGY and Hormonal range

Gastroenterology

General and OTC medicines

Gynecology and Fertility

Hepatology

Hypertension/ Blood Pressure

Nutraceuticals, Multivitamins and Multiminerals

Sedative or Antianxiety

Stimulant

Urology

Glycopyrronium 25 mcg + Formoterol Fumarate 6 mcg at Best Price for PCD Pharma Franchise in Respiratory Care

Glycopyrronium 25 mcg + Formoterol Fumarate 6 mcg at Best Price from Leading 3rd Party Manufacturers in India for Respiratory Health

Glycopyrronium 25 mcg + Formoterol Fumarate 6 mcg at Best Price from Top Pharmaceutical Exporters in India for Asthma and COPD

Glycopyrronium 25 mcg + Formoterol Fumarate 6 mcg at Best Price from Top Pharma Companies in India for Pulmonary Care

Glycopryl F Best Price in Respiratory Care Franchise for Asthma & COPD Management

Glycopryl F Rota Cap

Composition : Glycopyrronium 25 mcg + Formoterol Fumarate 6 mcg

Dosage Form : Rota cap

Packaging Type : in a bottle with carton

Packaging : 30 Capsules

Price : ₹1/-

Please Contact For Best Price

Glycopryl F is a specialized inhalation medication designed for the effective management of chronic obstructive pulmonary disease (COPD). Each Rota Cap contains a precise combination of Glycopyrronium (25 mcg) and Formoterol Fumarate (6 mcg), which work synergistically to provide long-lasting relief from respiratory symptoms.

Glycopyrronium is an anticholinergic agent that helps to relax and open the airways by blocking the action of acetylcholine, a neurotransmitter that can cause bronchoconstriction. This action leads to improved airflow and reduced breathlessness. Formoterol Fumarate, a long-acting beta-agonist (LABA), complements this effect by stimulating beta-2 adrenergic receptors in the lungs, resulting in further bronchodilation. Together, these components help to alleviate symptoms such as wheezing, coughing, and shortness of breath, enhancing the quality of life for individuals with COPD.

About the Product

Common side effects may include dry mouth, headache, dizziness, and palpitations. Some patients may experience throat irritation or cough. It is important to monitor for any unusual or severe reactions.

Glycopryl F is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adults.

Glycopryl F should be used only as directed by a healthcare professional. Do not exceed the recommended dosage, and consult a doctor if symptoms persist or worsen.

Store Glycopryl F in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children to ensure safety.